APOE and obstructive sleep apnea syndrome: We expected APOE4 carriers to exhibit altered sleep architecture (e.g. lower REM-sleep duration and greater sleep fragmentation) compared to non-carriers, especially in subgroups more vulnerable to cognitive decline (e.g. older participants, women, and participants with OSA).